Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-26-031661
Filing Date
2026-05-07
Accepted
2026-05-07 06:54:17
Documents
65
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sttk-20260331.htm   iXBRL 10-Q 649229
2 EX-10.1 ibc-shattucklabs_1stamen.htm EX-10.1 1868
3 EX-10.2 ibcbankplazasecondamendm.htm EX-10.2 1563
4 EX-31.1 sub-certxsection302xceoxq1.htm EX-31.1 18187
5 EX-31.2 sub-certxsection302xcfoxq1.htm EX-31.2 18119
6 EX-32.1 sub-certxsection906ofthesa.htm EX-32.1 9806
12 GRAPHIC ibc-shattucklabs_1stamen001.jpg GRAPHIC 221021
13 GRAPHIC ibc-shattucklabs_1stamen002.jpg GRAPHIC 273953
14 GRAPHIC ibc-shattucklabs_1stamen003.jpg GRAPHIC 82086
15 GRAPHIC ibc-shattucklabs_1stamen004.jpg GRAPHIC 72330
16 GRAPHIC ibc-shattucklabs_1stamen005.jpg GRAPHIC 79229
17 GRAPHIC ibcbankplazasecondamendm001.jpg GRAPHIC 176772
18 GRAPHIC ibcbankplazasecondamendm002.jpg GRAPHIC 243359
19 GRAPHIC ibcbankplazasecondamendm003.jpg GRAPHIC 62004
20 GRAPHIC ibcbankplazasecondamendm004.jpg GRAPHIC 71213
  Complete submission text file 0001628280-26-031661.txt   6373786

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sttk-20260331.xsd EX-101.SCH 31187
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sttk-20260331_cal.xml EX-101.CAL 36986
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sttk-20260331_def.xml EX-101.DEF 162156
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sttk-20260331_lab.xml EX-101.LAB 515650
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sttk-20260331_pre.xml EX-101.PRE 348598
69 EXTRACTED XBRL INSTANCE DOCUMENT sttk-20260331_htm.xml XML 488641
Mailing Address 500 W. 5TH STREET AUSTIN TX 78701
Business Address 500 W. 5TH STREET AUSTIN TX 78701 512-900-4690
Shattuck Labs, Inc. (Filer) CIK: 0001680367 (see all company filings)

EIN.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39593 | Film No.: 26950732
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)